Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) today announced the appointment of John Butler to its board of directors. Mr. Butler serves ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE